logo

Cell Analysis Instruments Market Size (2024 - 2029)

The cell analysis instruments market is projected to experience significant growth, driven by the increased demand for cell count and viability tests during the COVID-19 pandemic, which highlighted the importance of these instruments. The market's expansion is further supported by the rising global cancer burden and advancements in the biotech industry and cell biology research. Strategic initiatives such as product launches, collaborations, and acquisitions by key industry players are also contributing to the market's positive trajectory. However, the high costs associated with cell analysis and complex regulatory environments may pose challenges to market growth.

Home Market Analysis Healthcare Research Medical Devices Research Medical Supplies Research Medical Instruments Research Laboratory Medical Instruments Research Cell Analysis Instruments Market Market Size

Market Size of Cell Analysis Instruments Industry

Cell Analysis Instruments Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
CAGR 7.10 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Cell Analysis Instruments Market Major Players

*Disclaimer: Major Players sorted in no particular order

Cell Analysis Instruments Market Analysis

The cell analysis instruments market is expected to register a CAGR of 7.1% over the forecast period.

COVID-19 had a significant impact on the cell analysis instruments market since cell count and viability tests were widely carried out during the pandemic. According to an article published in February 2022 in News Medical life sciences, the number of WBC cell counts is a crucial indicator of inflammation; higher than 11,000 WBCs per unit microliter of blood counts may affect COVID-19 patients' hospital discharge and mortality rates. Similarly, as per an article published in June 2021 in the BMC journal, a higher WBC count ( 6.16 10^9/L) should be given more attention in the treatment of COVID-19. Developments such as these put cell analysis at the forefront during the pandemic and have contributed greatly to the growth of the market, which is expected to continue its positive, upward trend in the coming years.

Another factor that has played into the growth of the market is the growing burden of cancer across the globe and the expanding biotech industry and research in cell biology. For instance, per an American Cancer Society 2022 update, 1,918,030 new cancer cases were estimated in the United States in 2022. Furthermore, cell analysis in cancer is widely used by researchers to identify various criteria. An article published in November 2022 in the Nature journal mentioned that researchers performed a pan-cancer analysis on 226 samples across 10 solid cancer types to profile the tumor microenvironment (TME) at single-cell resolution, illustrating the commonalities/plasticity of heterogenous CAFs (cancer-associated fibroblasts).

Furthermore, product launches, strategic collaborations, and acquisitions by key players are expected to drive market growth over the forecast period. For instance, in August 2022, DeNovix Inc, the manufacturer of the award-winning CellDrop Automated Cell Counter, developed two dedicated nuclei counting apps capable of differentiating isolated nuclei and intact cells from debris. The CellDrop Series is a line of image-based, automated cell counters. Systems include a high-definition 7-inch touchscreen for live preview and instant review of results.

While several developments predict growth, the high cost of cell analysis and complex regulatory scenarios are anticipated to restrain the market growth over the forecast period.

Cell Analysis Instruments Industry Segmentation

As per the scope of the report, cell analysis deals with the study of cells, which are isolated from tissues in multicellular organisms and unicellular organisms. Cellular analysis plays a vital role in gene identification, protein identification, epigenomics, and other life science-related areas. It is a natural process to study the genetic and phenotypical characteristics of an organism. Cell analysis instruments include consumables such as reagents, assays, kits, and instruments that are required during cell analysis.

The cell analysis instruments market is segmented by Product (Instruments and Consumables), Application (Cell Counting, Cell Viability, Cell Identification, Target Identification, PCR, Others), End-User (Academic and Research Institutes, Pharmaceutical & Biotechnology Companies, Others), and Geography (North America, Europe, Asia-Pacific, Middle East, and Africa, South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above-mentioned segments.

By Product
Instruments
Microscopes
Flow Cytometers
Spectrophotometers
Cell Microarrays
Other Products
Consumables
By Application
Cell Counting
Cell Viability
Cell Identification
Target Identification
PCR
Other Applications
By End-User
Academic and Research Institutes
Pharmaceutical & Biotechnology Companies
Other End-Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Cell Analysis Instruments Market Size Summary

The cell analysis instruments market is poised for significant growth, driven by the increasing demand for advanced diagnostic and research tools in various fields, including oncology and biotechnology. The market's expansion is largely attributed to the heightened focus on cell counting and viability tests, which gained prominence during the COVID-19 pandemic. This surge in demand has been further bolstered by the rising incidence of cancer globally, prompting extensive research and development in cell biology. The market is characterized by the introduction of innovative products and technologies, such as automated cell counters and advanced hematology analyzers, which are enhancing the accuracy and efficiency of cell analysis. Strategic collaborations and acquisitions among key industry players are also contributing to the market's robust growth trajectory.

North America is expected to maintain a substantial share of the market, supported by increased funding for cell-based research and a high prevalence of cancer. The region's market growth is further fueled by the presence of major companies and their continuous efforts in research and development. The competitive landscape of the cell analysis instruments market is moderately fragmented, with both local and global players vying for market share. While international companies like Thermo Fisher Scientific and Sartorius AG dominate the market, there is a notable presence of local players in developing countries. The market's future growth is anticipated to be driven by technological advancements and the emergence of new players, as well as ongoing innovations in cell analysis technologies.

Explore More

Cell Analysis Instruments Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increase in Burden of Chronic Diseases

      2. 1.2.2 Growing Biotech Industry and Research in Cell Biology

    3. 1.3 Market Restraints

      1. 1.3.1 High Cost of Cell Analysis

      2. 1.3.2 Complex Regulatory Scenario

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD Million)

    1. 2.1 By Product

      1. 2.1.1 Instruments

        1. 2.1.1.1 Microscopes

        2. 2.1.1.2 Flow Cytometers

        3. 2.1.1.3 Spectrophotometers

        4. 2.1.1.4 Cell Microarrays

        5. 2.1.1.5 Other Products

      2. 2.1.2 Consumables

    2. 2.2 By Application

      1. 2.2.1 Cell Counting

      2. 2.2.2 Cell Viability

      3. 2.2.3 Cell Identification

      4. 2.2.4 Target Identification

      5. 2.2.5 PCR

      6. 2.2.6 Other Applications

    3. 2.3 By End-User

      1. 2.3.1 Academic and Research Institutes

      2. 2.3.2 Pharmaceutical & Biotechnology Companies

      3. 2.3.3 Other End-Users

    4. 2.4 Geography

      1. 2.4.1 North America

        1. 2.4.1.1 United States

        2. 2.4.1.2 Canada

        3. 2.4.1.3 Mexico

      2. 2.4.2 Europe

        1. 2.4.2.1 Germany

        2. 2.4.2.2 United Kingdom

        3. 2.4.2.3 France

        4. 2.4.2.4 Italy

        5. 2.4.2.5 Spain

        6. 2.4.2.6 Rest of Europe

      3. 2.4.3 Asia-Pacific

        1. 2.4.3.1 China

        2. 2.4.3.2 Japan

        3. 2.4.3.3 India

        4. 2.4.3.4 Australia

        5. 2.4.3.5 South Korea

        6. 2.4.3.6 Rest of Asia-Pacific

      4. 2.4.4 Middle East and Africa

        1. 2.4.4.1 GCC

        2. 2.4.4.2 South Africa

        3. 2.4.4.3 Rest of Middle East and Africa

      5. 2.4.5 South America

        1. 2.4.5.1 Brazil

        2. 2.4.5.2 Argentina

        3. 2.4.5.3 Rest of South America

Cell Analysis Instruments Market Size FAQs

The Cell Analysis Instruments Market is projected to register a CAGR of 7.10% during the forecast period (2024-2029)

Becton Dickinson and Company, Sartorius AG, Danaher Corporation, Merck KGaA and Thermo Fisher Scientific are the major companies operating in the Cell Analysis Instruments Market.

Cell Analysis Instruments Report Snapshots

Cell Analysis Instruments Market - Growth, Trends, COVID-19 Impact, and Forecasts (2024 - 2029)